Cargando…

Targeted Therapy for Metastatic Renal Carcinoma: an Update

Conventional chemotherapy is associated with poor outcomes in metastatic renal cell carcinoma (RCC). Advances in the understanding of tumor molecular biology and the implementation of new drugs that target these molecular pathways have increased the arsenal against advanced RCC and improved outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Silva, Rodrigo Donalisio, Gustafson, Diedra, Nogueira, Leticia, Werahera, Priya N., Molina, Wilson R., Kim, Fernando J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Codon Publications 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345523/ https://www.ncbi.nlm.nih.gov/pubmed/28326251 http://dx.doi.org/10.15586/jkcvhl.2014.14

Ejemplares similares

Current issues in patient safety in surgery: a review
por: Kim, Fernando J., et al.
Publicado: (2015)

Are outpatient transperineal prostate biopsies without antibiotic prophylaxis equivalent to standard transrectal biopsies for patient safety and cancer detection rates?A retrospective cohort study in 222 patients
por: Islam, Majdee, et al.
Publicado: (2021)

A new patient safety smartphone application for prevention of “forgotten” ureteral stents: results from a clinical pilot study in 194 patients
por: Molina, Wilson R., et al.
Publicado: (2017)

Targeted therapy for metastatic renal cell carcinoma
por: Patel, P H, et al.
Publicado: (2006)

Update on the treatment of metastatic renal cell carcinoma
por: Medina López, Rafael Antonio, et al.
Publicado: (2022)

The Cancer
por: da Silva, Rodrigo Donalisio, et al.
Publicado: (2015)

The Role of Targeted Therapy in Metastatic Renal Cell Carcinoma
por: Unnithan, Jaya, et al.
Publicado: (2007)

Prostate Cancer – Local Treatment after Radiorecurrence: Salvage Cryoablation
por: da Silva, Rodrigo Donalisio, et al.
Publicado: (2018)

Significance of Surgical Plume Obstruction During Laparoscopy
por: da Silva, Rodrigo Donalisio, et al.
Publicado: (2014)

The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
por: Rathi, Nityam, et al.
Publicado: (2019)

Targeted Therapies in Advanced and Metastatic Urothelial Carcinoma
por: Katims, Andrew B., et al.
Publicado: (2022)

A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma
por: Mihály, Z, et al.
Publicado: (2012)

Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy
por: Wang, Lisha, et al.
Publicado: (2014)

Targeting Cardiovascular Adverse Events of Metastatic Renal Cell Carcinoma Therapies
por: Guha, Avirup, et al.
Publicado: (2022)

Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities
por: Graves, Angela, et al.
Publicado: (2013)

Updating the Targeted Therapy Paradigm for Patients With Metastatic NSCLC
por: Florez (DUMA), Narjust, et al.
Publicado: (2023)

Duodenal Bleeding from Metastatic Renal Cell Carcinoma
por: Rustagi, Tarun, et al.
Publicado: (2011)

Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies
por: Grünwald, V, et al.
Publicado: (2011)

The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
por: Yu, Xiaoteng, et al.
Publicado: (2015)

Does Bone-targeted Therapy Benefit Patients with Metastatic Renal Cell Carcinoma?
por: Wong, Emily C.L., et al.
Publicado: (2019)

Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma
por: Dawsey, Scott J., et al.
Publicado: (2021)

Systemic therapy in metastatic renal cell carcinoma
por: Bedke, Jens, et al.
Publicado: (2016)

Sequential Therapy in Metastatic Renal Cell Carcinoma
por: Hirsch, Bradford R., et al.
Publicado: (2016)

An Overview of Systemic Targeted Therapy in Renal Cell Carcinoma, with a Focus on Metastatic Renal Cell Carcinoma and Brain Metastases
por: Semenescu, Liliana Eleonora, et al.
Publicado: (2023)

Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
por: Procopio, G, et al.
Publicado: (2012)

Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
por: Nerich, Virginie, et al.
Publicado: (2014)

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma
por: Stenehjem, David D., et al.
Publicado: (2019)

Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy
por: Teishima, Jun, et al.
Publicado: (2021)

Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015)

Carcinoid tumor of the verumontanum (colliculus seminalis) of the prostatic urethra with a coexisting prostatic adenocarcinoma: a case report
por: Smith, Maxwell, et al.
Publicado: (2010)

Axitinib in sequential therapy in metastatic renal cell carcinoma
por: Kuchar, Agata, et al.
Publicado: (2016)

Update on the Treatment of Metastatic Urothelial Carcinoma
por: Bukhari, Nedal, et al.
Publicado: (2018)

Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
por: Song, Yan, et al.
Publicado: (2016)

Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma
por: Chrom, Pawel, et al.
Publicado: (2018)

Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma
por: Chow, Ryan D, et al.
Publicado: (2023)

Association of lncRNA and transcriptome intersections with response to targeted therapy in metastatic renal cell carcinoma
por: Tesarova, Tereza, et al.
Publicado: (2023)

Prognosis of metastatic renal cell carcinoma with first‐line interferon‐α therapy in the era of molecular‐targeted therapy
por: Kawano, Yoshiaki, et al.
Publicado: (2016)

Updates on Molecular Targeted Therapies for Intraparenchymal CNS Metastases
por: Sharma, Akanksha, et al.
Publicado: (2021)

The current status of immunobased therapies for metastatic renal-cell carcinoma
por: Sathianathen, Niranjan J, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ekels8t4j2b83sarietv1juhp9